The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus
Open Access
- 30 January 2021
- journal article
- Published by Elsevier BV in Informatics in Medicine Unlocked
- Vol. 23, 100529
- https://doi.org/10.1016/j.imu.2021.100529
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Fru Berta Kamprads Stiftelse
This publication has 25 references indexed in Scilit:
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in AdultsJAMA, 2016
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- Advantages and Challenges in Drug Re-ProfilingJournal of Pharmacovigilance, 2015
- g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA CalculationsJournal of Chemical Information and Modeling, 2014
- Combinatorial drug therapy for cancer in the post-genomic eraNature Biotechnology, 2012
- HexServer: an FFT-based protein docking server powered by graphics processorsNucleic Acids Research, 2010
- Energetic Decomposition with the Generalized-Born and Poisson−Boltzmann Solvent Models: Lessons from Association of G-Protein ComponentsThe Journal of Physical Chemistry B, 2010
- Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variantsAntiviral Research, 2006
- Electrostatics of nanosystems: Application to microtubules and the ribosomeProceedings of the National Academy of Sciences of the United States of America, 2001
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000